All Updates

All Updates

icon
Filter
Geographic expansion
Onego Bio establishes US headquarters in San Diego to advance animal-free egg protein production
Plant-based Dairy & Egg
Nov 19, 2024
Last week:
Funding
Plantible Foods raises USD 30 million in Series B funding to expand manufacturing operations
Plant-based Dairy & Egg
Nov 15, 2024
Product updates
Armored Fresh launches new oat milk parmesan cheese alternatives
Plant-based Dairy & Egg
Nov 15, 2024
Funding
Shiru raises USD 16 million in Series B funding to expand ingredient portfolio
Plant-based Dairy & Egg
Nov 14, 2024
Product updates
Naplasol launches two new mycoprotein products
Plant-based Dairy & Egg
Nov 1, 2024
Partnerships
PoLoPo partners with CSM Ingredients to develop egg protein alternative for baking
Plant-based Dairy & Egg
Oct 31, 2024
Partnerships
Revyve partners with Daymer Ingredients to distribute yeast-based egg alternatives in UK
Plant-based Dairy & Egg
Oct 30, 2024
M&A
Oddlygood acquires UK plant-based brand Rude Health
Plant-based Dairy & Egg
Oct 29, 2024
Product updates
Dreamfarm launches vegan ricotta made from nuts
Plant-based Dairy & Egg
Oct 24, 2024
Product updates
Edenesque launches new plant-based milk product line
Plant-based Dairy & Egg
Oct 21, 2024
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Nov 19, 2024

Onego Bio establishes US headquarters in San Diego to advance animal-free egg protein production

Geographic expansion

  • Onego Bio, a Finnish food technology company, has opened a 5,000 sq ft commercial headquarters in San Diego, California. The company is also planning its first industrial-scale manufacturing facility in the US, which will have a 2-million-liter fermentation capacity, equivalent to 6 million laying hens annually.

  • The facility includes office spaces, advanced laboratory capabilities, and a test kitchen for demonstrating applications of its Bioalbumen product, an animal-free egg protein created through precision fermentation.

  • The company chose San Diego for its strong biotechnology ecosystem and proximity to leading research institutions, universities, and food tech innovators. The location will support Onego Bio's North American commercialization strategy, where regulatory conditions are expected to enable faster market launch than Europe.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.